Company / EPS (Diluted)
X4 Pharmaceuticals, Inc EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$17.07
FY2025
5-year range
-$79.15 / -$1.52
FY2021-FY2025
Trend
-1023.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1023% YoY in FY2025, a notable deviation from the 5-year average annual change of -184%.
Based on SEC 10-K filings.
-17.07 in FY2025.
Declined from $-3.09 to $-17.07 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 1023.0% year-over-year.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$17.07 | -1023.0% |
| FY2024 | -$1.52 | +50.8% |
| FY2022 | -$3.09 | +33.3% |
| FY2021 | -$4.63 | +94.2% |
| FY2020 | -$79.15 | -76.7% |
| FY2018 | -$44.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026